Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Location: Hackensack NJ, The Bronx NY, Philadelphia PA, Boston MA,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
for
Breast Cancer, Metastatic Triple-Negative Breast Cancer
Location: Hackensack NJ, Montvale NJ, New York NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05570253
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Hackensack NJ, New Hyde Park NY, Stony Brook NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Hackensack NJ, New York NY, Newark NJ, The Bronx NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase3, Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Hackensack NJ, New York NY, New Haven CT, Boston MA,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
for
Proteinuric Kidney Disease
Location: Hackensack NJ, Newark NJ, New York NY, The Bronx NY,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 10 - 65
Code: NCT05312879
Phase2, Phase3, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Hackensack NJ, Montvale NJ, Livingston NJ, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Hackensack NJ, Livingston NJ, New York NY, The Bronx NY,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase3, Recruiting
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Hackensack NJ, The Bronx NY, New York NY, Stamford CT,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase3, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Hackensack NJ, New York NY, Morristown NJ, New Haven CT,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
for
Diffuse Intrinsic Pontine Glioma,
Location: Hackensack NJ, New York NY, Philadelphia PA,
Sponsor: University of California, San Francisco
Sex: All
Age: 2 - 39
Code: NCT05009992
Phase2, Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Hackensack NJ, New York NY, The Bronx NY,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase3, Recruiting
Pivotal Study for the Cardiac Performance System (CPS)
for
Cardiovascular Diseases
Location: Hackensack NJ, New York NY, Neptune City NJ,
Sponsor: Sensydia Corporation
Sex: All
Age: 18+
Code: NCT06870591
Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer